Belle Frank is chief strategy officer, global health practice at VMLY&R.
Marketers answer the question: How can AI, marketing tech, and sophisticated analytics be used to help find participants for clinical research?
President Trump’s blueprint to lower drug prices hasn’t made it out of the brainstorm phase.
Tod Loofbourrow is CEO of ViralGains.
Texas Judge Reed O’Connor’s ruling on the ACA could affect both insurers and pharma.
Three of the industry’s top data architects reflect on their careers, opine on pharma’s “data revolution,” muse on the future of AI in healthcare, and unravel the secrets of their universe.